Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 23 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

13%

3 trials in Phase 3/4

Results Transparency

20%

3 of 15 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (8)
P 2 (7)
P 3 (2)
P 4 (1)

Trial Status

Completed15
Unknown5
Recruiting2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT06615843Not ApplicableRecruitingPrimary

Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up

NCT04061967Not ApplicableRecruiting

Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer.

NCT04807166Phase 2Active Not Recruiting

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

NCT04746053Not ApplicableCompletedPrimary

Ovarian Function and Gynecological Profile of Patients Carrying a Pathogenic Variant of the HNF1B Gene (GYN-HNF1)

NCT06134596UnknownPrimary

Correlation of Clitoral Hood and Labia Minora Measurements and Female Genital Self Image Scale (FGSIS) Scores in Women

NCT01462890Phase 3CompletedPrimary

Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer

NCT03562897Phase 2Completed

Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

NCT01526668Not ApplicableCompleted

Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy

NCT04858919Not ApplicableCompleted

Transrectal and 3D Transabdominal Ultrasound Compared to Vaginoscopy in Diagnosing Virgins With Genital Lesions

NCT03677336Phase 4Completed

Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI

NCT04556071Phase 2Unknown

Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer

NCT04566952Phase 2Unknown

Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer

NCT01628432Not ApplicableCompletedPrimary

Effect of Salpingectomy During Conservative Hysterectomy

NCT02698527Not ApplicableCompletedPrimary

The Effect of Buffered Lidocaine Versus Nonbuffered Lidocaine on Pain Scores During Infiltration for Vulvar Biopsies

NCT02642835CompletedPrimary

A Long Term Follow up of Anterior Meshes for Recurrent Prolapse

NCT02747641Not ApplicableCompleted

Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects

NCT01456962Completed

Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract

NCT01460979Phase 2CompletedPrimary

Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma

NCT00365716Phase 2Completed

Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)

NCT02097446Phase 3UnknownPrimary

Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy

Scroll to load more

Research Network

Activity Timeline